Onconetix, Inc. - Common Stock (ONCO)

0.5610
-0.0250 (-4.27%)
NASDAQ · Last Trade: Oct 30th, 11:28 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.5860
Open0.5430
Bid0.5000
Ask0.5400
Day's Range0.5211 - 0.5849
52 Week Range0.3423 - 200.00
Volume1,190,005
Market Cap12.44M
PE Ratio (TTM)0.0002
EPS (TTM)3,049.1
Dividend & YieldN/A (N/A)
1 Month Average Volume4,903,607

Chart

About Onconetix, Inc. - Common Stock (ONCO)

Onconetix Inc is a biotechnology company focused on advancing cancer diagnostics and therapeutics. The company leverages cutting-edge research and technology to develop innovative solutions aimed at improving patient outcomes in oncology. By harnessing the power of molecular biology and genomics, Onconetix aims to enhance the ability to detect and characterize tumors, enabling more effective treatment strategies tailored to individual patients. The company's commitment to precision medicine drives its ongoing efforts to contribute to the evolving landscape of cancer care through scientific discovery and collaboration. Read More

News & Press Releases

Next-Gen Biotech: RXRX, OCGN, SNTI, VIVS, ONCO Stocks to Watch
AI drug discovery, retinal gene therapy, human tissue testing and corporate transactions put five Nasdaq-listed companies in focus, alongside larger healthcare names PFE, MRNA and LLY.
Via AB Newswire · October 28, 2026
Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement
Echo Tabletop Priced at $11,950 and Echo Full Body at $59,950; First Production Run of 250 Units Available for 2027 Delivery; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp.
By Onconetix, Inc. · Via GlobeNewswire · October 27, 2026
After-Hours Movers: SNTI, BRAI, CLS Rise; SPRC, DVLT Fallchartmill.com
Via Chartmill · October 26, 2026
Onconetix Announces Reverse Stock Split
CINCINNATI, Ohio, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”), today announced that its Board of Directors has approved a one-for-ten (1-for-10) reverse stock split of the Company’s outstanding common stock. The reverse split is expected to become effective at 12:01 a.m. Eastern Time on November 6, 2026. The Company’s common stock has been assigned a new CUSIP number, 68237Q500, in connection with the reverse stock split.
By Onconetix, Inc. · Via GlobeNewswire · October 26, 2026
Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
Additional $500,000 Advance to Support Growth Initiatives and Working Capital of Realbotix LLC
By Onconetix, Inc. · Via GlobeNewswire · October 23, 2026
Let's take a look at the stocks that are in motion in today's session.chartmill.com
Via Chartmill · October 8, 2026
The trading volume of these stocks is deviating from the norm in today's session.chartmill.com
Via Chartmill · September 28, 2026
Curious about the stocks that are showing activity after the closing bell on Friday?chartmill.com
Via Chartmill · September 25, 2026
Unusual volume stocks are being observed in Friday's session.chartmill.com
Via Chartmill · September 25, 2026
Gapping stocks in Friday's sessionchartmill.com
Via Chartmill · September 25, 2026
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · September 23, 2026
CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
Initial Advance of $2.5 Million to Realbotix LLC to Support Growth and Working Capital; Non-Interest Bearing Facility Is Automatically Cancelled and Discharged in Full Upon Closing of Pending Acquisition
By Onconetix, Inc. · Via GlobeNewswire · September 14, 2026
Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
Initial Advance of $2.5 Million to Realbotix LLC to Support Growth and Working Capital; Non-Interest Bearing Facility Is Automatically Cancelled and Discharged in Full Upon Closing of Pending Acquisition
By Onconetix, Inc. · Via GlobeNewswire · September 14, 2026
These stocks are moving in today's pre-market sessionchartmill.com
Via Chartmill · September 8, 2026
Curious about the stocks that are showing activity after the closing bell on Monday?chartmill.com
Via Chartmill · September 7, 2026
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · September 4, 2026
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events
Pilot Tests Humanoid Robots as Presenters, Hosts, and Brand Ambassadors Before Live Audiences, Extending Robot Capabilities Beyond One-on-One Interaction into Dynamic, Audience-Facing Environments; Onconetix Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp.
By Onconetix, Inc. · Via GlobeNewswire · September 3, 2026
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series
Entertainment Industry Agreement Reflects Real-World Adoption of Humanoid Robotics Technology Across Education, Healthcare, Hospitality, and Customer Engagement; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp.
By Onconetix, Inc. · Via GlobeNewswire · August 6, 2026
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG
Proteomedix Co-Founder and Proclarix® Co-Developer Returns to Company’s Board; Thomas Meier, PhD Re-Elected as Chairman at Annual General Meeting
By Onconetix, Inc. · Via GlobeNewswire · August 5, 2026
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market session. Onconetix (NASDAQ:ONCO) shares moved upwards by 27.46% to $0.96. The company's market cap stands at $3.0
Via Benzinga · July 29, 2026
Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation
Realbotix Robots and AI to Deploy in Evidence-Based Pilot Designed to Improve Wellbeing and Address Loneliness Among Older Adults in UK Care Settings; Realbotix Becomes Accredited Supplier on Bloom’s Public Sector Marketplace; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp.
By Onconetix, Inc. · Via GlobeNewswire · July 7, 2026
NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Development of PNKP Inhibitors in Oncology Drug Development
AUSTIN, Texas, June 26, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Next-Generation DNA Repair Therapies Open New Frontiers in Oncology,” featuring Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF).
By NetworkNewsWire · Via GlobeNewswire · June 26, 2026
Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
Salamanca City Central School District on Seneca Nation Reservation to Deploy Optio and Realbotix M-Series Humanoid Robot; Pilot to Expand to Approximately 500 High School Students in Fall 2026; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp.
By Onconetix, Inc. · Via GlobeNewswire · June 24, 2026
What's going on in today's sessionchartmill.com
Via Chartmill · May 19, 2026
Which stocks are most active on Tuesday?chartmill.com
Via Chartmill · May 19, 2026